Search for Clinical Trial Results
Acute Myelomonocytic Leukemia - 190 Studies Found
Status | Study |
Terminated |
Study Name: Omacetaxine Mepesuccinate, Cytarabine, and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: CPX-351 in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Condition:
Interventions: |
Active, not recruiting |
Study Name: Lenalidomide and Combination Chemotherapy in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Active, not recruiting |
Study Name: Treatment for Relapsed/Refractory AML Based on a High Throughput Drug Sensitivity Assay Condition:
|
Active, not recruiting |
Study Name: Metformin+Cytarabine for the Treatment of Relapsed/Refractory AML Condition:
|
Active, not recruiting |
Study Name: Azacitidine, Cytarabine, and Mitoxantrone Hydrochloride in Treating Patients With High-Risk Acute Myeloid Leukemia Condition:
Interventions: |
Withdrawn |
Study Name: Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
|
Completed |
Study Name: Idarubicin, Cytarabine, and Pravastatin Sodium in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndromes Condition:
|
Active, not recruiting |
Study Name: Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Condition:
Interventions: |
Completed |
Study Name: Lithium Carbonate and Tretinoin in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia Condition:
Interventions: |